Frontlight ResearchEarly access
Trial site
Inland Empire Clinical Trials, LLC
- 3running trials
- 9closed trials
The trials here
What the 12 trials at this site are about, from their registry records.
- Conditions
- Fatty liver disease (MASLD/MASH)8 trials
- Liver cirrhosis5 trials
- High blood pressure3 trials
- Ulcerative colitis1 trial
- Phase
- Phase 27 trials
- Phase 33 trials
- Phase 12 trials
- Status
- Completed5 trials
- Terminated4 trials
- Recruiting2 trials
- Active, not recruiting1 trial
- Lead sponsor
- Boehringer Ingelheim6 trials
- Eli Lilly and Company3 trials
- NeuroBo Pharmaceuticals Inc.1 trial
- Pfizer1 trial
- Takeda1 trial
Running trials
Recruiting
Recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Fatty liver disease (MASLD/MASH)2 recruiting
- Liver cirrhosis1 recruiting
Closed trials
Completed
Terminated
Completed
Study to Evaluate the Efficacy and Safety of DA-1241 in Subjects With Presumed NASH
Terminated
Terminated
Completed
Terminated
Completed
Metabolic Interventions to Resolve Non-alcoholic Steatohepatitis (NASH) With Fibrosis (MIRNA)
Completed
A Study of Tirzepatide (LY3298176) in Participants With Nonalcoholic Steatohepatitis (NASH)
Site data: ClinicalTrials.govUpdated 13 Nov 2026